Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity.
- Published In:
- Molecular metabolism, 8, 203-210 (2018)
- Database ID:
- RPEP-03594
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03594APA
Boyle, Christina Neuner; Lutz, Thomas Alexander; Le Foll, Christelle. (2018). Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity.. Molecular metabolism, 8, 203-210. https://doi.org/10.1016/j.molmet.2017.11.009
MLA
Boyle, Christina Neuner, et al. "Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity.." Molecular metabolism, 2018. https://doi.org/10.1016/j.molmet.2017.11.009
RethinkPeptides
RethinkPeptides Research Database. "Amylin - Its role in the homeostatic and hedonic control of ..." RPEP-03594. Retrieved from https://rethinkpeptides.com/research/boyle-2018-amylin-its-role-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.